Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Id2 gene helps keep hair follicle stem cells inactive.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

DA-9401 helps protect rat testis from finasteride damage.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

TCDD changes skin cell growth and keratin production in mice.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Metformin may help treat neuroendocrine tumors.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.